5-nitro-2-(3-phenylpropylamino)benzoic acid and Leukemia
5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Leukemia in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jiang, B | 1 |
Hattori, N | 1 |
Liu, B | 1 |
Nakayama, Y | 1 |
Kitagawa, K | 1 |
Inagaki, C | 1 |
Other Studies
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Leukemia
Article | Year |
---|---|
Suppression of cell proliferation with induction of p21 by Cl(-) channel blockers in human leukemic cells.
Topics: Blotting, Northern; Blotting, Western; Cell Cycle; Cell Division; Chloride Channels; CLC-2 Chloride | 2004 |